Panakeia improves patient outcomes
by making biomarker profiling faster
and more accessible for informing
diagnosis, treatment and drug development
It all begins with patient experience
The story of Panakeia begins with a patient-centred approach to innovation and is driven by empathy. Co-founder & CEO, Pahini Pandya, experienced first hand the anxiety that patients and their families suffer when waiting for a cancer diagnosis. Her experience compelled a desire to translate a decade in the field of cancer research into solutions addressing
these issues. She co-founded Panakeia via Entrepeneur First with the vision of making precision medicine accessible for patients all over the world. Today, Panakeia's team is leveraging strong, interdisciplinary expertise to develop solutions and together they are ushering in next generation of biomarker profiling.